首页 > 最新文献

Revue Du Praticien最新文献

英文 中文
[Anal fistulas: Sparing the sphincter]. [肛门瘘:保留括约肌]。
Q4 Medicine Pub Date : 2023-03-01
Vincent De Parades, Mohamed Amine Haouari, Nadia Fathallah, Lucas Spindler, Amélie Barré, Elise Pommaret, Paul Benfredj

Anal fistulas: SPARING THE SPHINCTER. Fistulotomy is the most used treatment for anal fistula. It is very effective with a cure rate of over 95% but carries a risk of incontinence. This has led to the development of various sphincter sparing techniques. The injection of biological glue or paste and the insertion of a plug have disappointing results and are expensive. The rectal advancement flap is still practised because of its cure rate of around 75% but it may result in some incontinence. Intersphincteric ligation of the fistula track and laser treatment are widely practised in France with cure rates between 60 and 70%. Video-assisted anal fistula treatment as well as injections of adipose tissue, stromal vascular fraction, platelet-enriched plasma and/or mesenchymal stem cells are emerging techniques for which even better results are expected.

肛门瘘:保留括约肌。瘘管切开术是肛瘘最常用的治疗方法。它非常有效,治愈率超过95%,但有尿失禁的风险。这导致了各种保留括约肌技术的发展。注射生物胶或生物膏剂和插入塞的效果令人失望,而且价格昂贵。直肠推进瓣治愈率达75%左右,但仍有部分患者出现尿失禁。括约肌间结扎瘘道和激光治疗在法国广泛应用,治愈率在60 - 70%之间。视频辅助肛瘘治疗以及注射脂肪组织、间质血管部分、富血小板血浆和/或间充质干细胞是新兴技术,有望取得更好的效果。
{"title":"[Anal fistulas: Sparing the sphincter].","authors":"Vincent De Parades,&nbsp;Mohamed Amine Haouari,&nbsp;Nadia Fathallah,&nbsp;Lucas Spindler,&nbsp;Amélie Barré,&nbsp;Elise Pommaret,&nbsp;Paul Benfredj","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Anal fistulas: </strong>SPARING THE SPHINCTER. Fistulotomy is the most used treatment for anal fistula. It is very effective with a cure rate of over 95% but carries a risk of incontinence. This has led to the development of various sphincter sparing techniques. The injection of biological glue or paste and the insertion of a plug have disappointing results and are expensive. The rectal advancement flap is still practised because of its cure rate of around 75% but it may result in some incontinence. Intersphincteric ligation of the fistula track and laser treatment are widely practised in France with cure rates between 60 and 70%. Video-assisted anal fistula treatment as well as injections of adipose tissue, stromal vascular fraction, platelet-enriched plasma and/or mesenchymal stem cells are emerging techniques for which even better results are expected.</p>","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"274-278"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9606153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recent advances in fecal incontinence treatment]. [大便失禁治疗的最新进展]。
Q4 Medicine Pub Date : 2023-03-01
Émilie Liot, Frédéric Ris, Joan Robert-Yap, Guillaume Meurette

RECENT ADVANCES IN FECAL INCONTINENCE TREATMENT. Anal incontinence is a chronic condition that affects nearly 10% of the general population. When anal leakage concerns the stool and is frequent, the impact on the quality of life is very important. Recent advances in non-invasive medical treatments and in operative approaches make it possible to provide for most patients an anorectal comfort compatible with a social life. The three main challenges for the future lie in the organization of screening for this condition which is still taboo and for which patients do not easily confide, in a better selection of patients to offer the most suitable treatments, and therefore a better understanding of the pathophysiological mechanisms; and finally in the establishment of algorithms which prioritize treatments according to their side effects and their effectiveness.

大便失禁治疗的最新进展。肛门失禁是一种影响近10%总人口的慢性疾病。当肛漏与大便有关且频繁时,对生活质量的影响是非常重要的。非侵入性医学治疗和手术方法的最新进展,使大多数患者有可能获得与社交生活相适应的肛肠舒适。未来的三个主要挑战是:组织对这种疾病的筛查,这仍然是禁忌,患者不容易吐露,在更好地选择患者提供最合适的治疗,从而更好地了解病理生理机制;最后在算法的建立中根据副作用和疗效对治疗进行优先排序。
{"title":"[Recent advances in fecal incontinence treatment].","authors":"Émilie Liot,&nbsp;Frédéric Ris,&nbsp;Joan Robert-Yap,&nbsp;Guillaume Meurette","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>RECENT ADVANCES IN FECAL INCONTINENCE TREATMENT. Anal incontinence is a chronic condition that affects nearly 10% of the general population. When anal leakage concerns the stool and is frequent, the impact on the quality of life is very important. Recent advances in non-invasive medical treatments and in operative approaches make it possible to provide for most patients an anorectal comfort compatible with a social life. The three main challenges for the future lie in the organization of screening for this condition which is still taboo and for which patients do not easily confide, in a better selection of patients to offer the most suitable treatments, and therefore a better understanding of the pathophysiological mechanisms; and finally in the establishment of algorithms which prioritize treatments according to their side effects and their effectiveness.</p>","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"296-299"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Malaria]. (疟疾)。
Q4 Medicine Pub Date : 2023-03-01
Oula Itani, Paul-Henri Consigny
{"title":"[Malaria].","authors":"Oula Itani, Paul-Henri Consigny","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"327-338"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Child health conferences: Huge expectations?] 儿童健康会议:巨大的期望?]
Q4 Medicine Pub Date : 2023-03-01
Élisabeth Martin-Lebrun, Stéphanie Eyssette-Guerreau
{"title":"[Child health conferences: Huge expectations?]","authors":"Élisabeth Martin-Lebrun, Stéphanie Eyssette-Guerreau","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"235"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Identification of cutaneous adverse drug reactions]. 【皮肤药物不良反应的鉴别】。
Q4 Medicine Pub Date : 2023-03-01
Saskia Ingen-Housz-Oro

IDENTIFICATION OF CUTANEOUS ADVERSE DRUG REACTIONS. Cutaneous adverse drug reactions are common. The most common are maculopapular exanthemas, which heal within a few days. However, clinical and biological signs of severity should be ruled out. Severe drug reactions include acute generalized exanthematous pustulosis, DRESS (drug reaction with eosinophilia and systemic symptoms), and epidermal necrolysis (Stevens-Johnson and Lyell syndromes). The search for the suspect drug is based on the questioning of the patient or his entourage and a chronological timeline. The treatment of drug eruption depends on its nosological type and the patient's background. For any severe drug reaction, hospitalization in a specialized units is necessary. Follow-up of epidermal necrolysis should be prolonged due to the frequency of disabling sequelae. All drug reactions, in particular the severe forms, must be declared to the pharmacovigilance services.

皮肤药物不良反应的鉴别。皮肤药物不良反应是常见的。最常见的是黄斑丘疹,几天内就会愈合。然而,临床和生物学的严重迹象应排除。严重的药物反应包括急性全身性脓疱病、DRESS(伴有嗜酸性粒细胞增多和全身性症状的药物反应)和表皮坏死松解(Stevens-Johnson和Lyell综合征)。对可疑药物的搜索是基于对患者或其随行人员的询问和时间顺序。药疹的治疗取决于其疾病类型和患者的背景。对于任何严重的药物反应,住院治疗是必要的。由于致残后遗症的频繁,表皮坏死松解的随访时间应延长。所有药物反应,特别是严重的药物反应,都必须向药物警戒部门申报。
{"title":"[Identification of cutaneous adverse drug reactions].","authors":"Saskia Ingen-Housz-Oro","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>IDENTIFICATION OF CUTANEOUS ADVERSE DRUG REACTIONS. Cutaneous adverse drug reactions are common. The most common are maculopapular exanthemas, which heal within a few days. However, clinical and biological signs of severity should be ruled out. Severe drug reactions include acute generalized exanthematous pustulosis, DRESS (drug reaction with eosinophilia and systemic symptoms), and epidermal necrolysis (Stevens-Johnson and Lyell syndromes). The search for the suspect drug is based on the questioning of the patient or his entourage and a chronological timeline. The treatment of drug eruption depends on its nosological type and the patient's background. For any severe drug reaction, hospitalization in a specialized units is necessary. Follow-up of epidermal necrolysis should be prolonged due to the frequency of disabling sequelae. All drug reactions, in particular the severe forms, must be declared to the pharmacovigilance services.</p>","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"307-313"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Novelties in proctology]. [肛肠科的新奇之处]。
Q4 Medicine Pub Date : 2023-03-01
Vincent De Parades, Aubert Manuel
{"title":"[Novelties in proctology].","authors":"Vincent De Parades, Aubert Manuel","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"269"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9760323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Novelties in proctology: 8 key messages]. [直肠科的新奇之处:8个关键信息]。
Q4 Medicine Pub Date : 2023-03-01
Vincent De Parades
{"title":"[Novelties in proctology: 8 key messages].","authors":"Vincent De Parades","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"300"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9760327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[How to explore pruritus?] 如何探查瘙痒?]
Q4 Medicine Pub Date : 2023-03-01
Émilie Brenaut, Laurent Misery
{"title":"[How to explore pruritus?]","authors":"Émilie Brenaut, Laurent Misery","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"326"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Intramedullary metastasis of lung carcinoma]. [肺癌髓内转移]。
Q4 Medicine Pub Date : 2023-03-01
Benjamin Teboul, Étienne Ghrenassia
{"title":"[Intramedullary metastasis of lung carcinoma].","authors":"Benjamin Teboul, Étienne Ghrenassia","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"304"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pruritus]. 瘙痒。
Q4 Medicine Pub Date : 2023-03-01
Émilie Brenaut, Laurent Misery
{"title":"[Pruritus].","authors":"Émilie Brenaut, Laurent Misery","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21248,"journal":{"name":"Revue Du Praticien","volume":"73 3","pages":"325-321"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9599877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revue Du Praticien
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1